{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:30Z","timestamp":1790299050321,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American Recovery and Reinvestment Act"},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["HHSN271200900019C"],"award-info":[{"award-number":["HHSN271200900019C"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.schres.2017.06.039","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T15:45:52Z","timestamp":1499528752000},"page":"4-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Demographic and clinical correlates of substance use disorders in first episode psychosis"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-8745","authenticated-orcid":false,"given":"Mary F.","family":"Brunette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim T.","family":"Mueser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Babbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piper","family":"Meyer-Kalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrine","family":"Cather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delbert G.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina R.","family":"Schooler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue E.","family":"Estroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley M.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9428-1231","authenticated-orcid":false,"given":"Patricia","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2017.06.039_bb0005","series-title":"Inaugural International Cannabis and Psychosis Conference, Melbourne","article-title":"Early intervention strategies for co-morbid cannabis use and psychosis","author":"Addington","year":"1999"},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0447.2006.00900.x","article-title":"Patterns, predictors and impact of substance use in early psychosis: a longitudinal study","volume":"115","author":"Addington","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.06.039_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary Depression Scale","volume":"22","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2017.06.039_bb0020","series-title":"Duration of Untreated Psychosis in Community Treatment Settings in the United States. Psychiatr Serv","author":"Addington","year":"2015"},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.06.039_bb0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.schres.2009.04.005","article-title":"Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study)","volume":"113","author":"Baeza","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.bp.106.024448","article-title":"Substance use in a population-based clinic sample of people with first-episode psychosis","volume":"190","author":"Barnett","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/schbul\/sbu095","article-title":"The impact of cannabis use on clinical outcomes in recent onset psychosis","volume":"41","author":"Barrowclough","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0040","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2017.06.039_bb0045","series-title":"Textbook of Schizophrenia","article-title":"Co-occurring substance use and other psychiatric disorders","author":"Brunette","year":"2016"},{"key":"10.1016\/j.schres.2017.06.039_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(01)00249-3","article-title":"Precipitation and determination of the onset and course of schizophrenia by substance abuse\u2014a retrospective and prospective study of 232 population-based first illness episodes","volume":"54","author":"B\u00fchler","year":"2002","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","article-title":"The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients","volume":"61","author":"Cacciola","year":"2001","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.schres.2017.06.039_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/NMD.0b013e318229d6bd","article-title":"The journey through cannabis use: a qualitative study of the experiences of young adults with psychosis","volume":"199","author":"Childs","year":"2011","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0065","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","article-title":"Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition","volume":"4","author":"Colizzi","year":"2017","journal-title":"Curr. Addict. Rep."},{"issue":"5","key":"10.1016\/j.schres.2017.06.039_bb0070","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions","volume":"64","author":"Compton","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2017.06.039_bb0075","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2009.09030311","article-title":"Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients","volume":"166","author":"Compton","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1017\/S0033291701003865","article-title":"The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-being","volume":"31","author":"Degenhardt","year":"2001","journal-title":"Psychol. Med."},{"issue":"Suppl. 17","key":"10.1016\/j.schres.2017.06.039_bb0085","doi-asserted-by":"crossref","first-page":"108","DOI":"10.15288\/jsads.2014.s17.108","article-title":"Case closed: research evidence on the positive public health impact of the age 21 minimum legal drinking age in the United States","volume":"75","author":"DeJong","year":"2014","journal-title":"J. Stud. Alcohol Drug Suppl."},{"issue":"9","key":"10.1016\/j.schres.2017.06.039_bb0090","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1017\/S0033291712000062","article-title":"Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender","volume":"42","author":"Dekker","year":"2012","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0095","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1037\/a0031256","article-title":"Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia","volume":"27","author":"Desmarais","year":"2013","journal-title":"Psychol. Addict. Behav."},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0100","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/schbul\/sbt181","article-title":"Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users","volume":"40","author":"Di Forti","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0105","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.jcp.0000130554.63254.3a","article-title":"Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence","volume":"24","author":"Dolder","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2017.06.039_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/yd.23319960203","article-title":"Assessing substance use disorder in persons with severe mental illness","volume":"70","author":"Drake","year":"1996","journal-title":"New Dir. Ment. Health Serv."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0115","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.schbul.a007097","article-title":"From stigma to discrimination: an analysis of community efforts to reduce the negative consequences of having a psychiatric disorder and label","volume":"30","author":"Estroff","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.schres.2017.06.039_bb0120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.12012co1c","article-title":"The effect of marijuana use on the risk for schizophrenia","volume":"73","author":"Evins","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0125","series-title":"Structured Clinical Interview for DSM-IV Axis-I Disorders - Patient Edition (SCID-I\/P, Version 2.0)","author":"First","year":"1996"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2008.07.004","article-title":"Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals","volume":"99","author":"Ford","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.schres.2017.06.039_bb0135","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1176\/appi.ajp.2010.09020189","article-title":"Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization","volume":"167","author":"Foti","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2017.06.039_bb0140","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eurpsy.2004.09.013","article-title":"Cannabis use and outcome of recent onset psychosis","volume":"20","author":"Grech","year":"2005","journal-title":"Eur. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.06.039_bb0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2003.08.001","article-title":"First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol","volume":"66","author":"Green","year":"2004","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2017.06.039_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0033291707000797","article-title":"Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study","volume":"38","author":"Harrison","year":"2008","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the national epidemiologic survey on alcohol and related conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schizophrenia deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.06.039_bb0170","series-title":"Evidence-Based Treatments for First Episode Psychosis: Components of Coordinated Specialty Care","author":"Heinssen","year":"2014"},{"issue":"1","key":"10.1016\/j.schres.2017.06.039_bb0175","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.schres.2015.11.027","article-title":"Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119)","volume":"170","author":"Helle","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1192\/bjp.bp.105.014308","article-title":"Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study","volume":"189","author":"Hides","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1751-7893.2007.00035.x","article-title":"Reductions in cannabis and other illicit substance use between treatment entry and early recovery in patients with first-episode psychosis","volume":"1","author":"Hinton","year":"2007","journal-title":"Early Interv. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.schres.2016.04.027","article-title":"Evidence for an agitated-aggressive syndrome in early-onset psychosis correlated with antisocial personality disorder, forensic history, and substance use disorder","volume":"175","author":"Huber","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0195","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1751-7893.2009.00133.x","article-title":"Lifetime history of substance misuse in first-episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms","volume":"3","author":"Kamali","year":"2009","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0205","article-title":"Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program","author":"Kane","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(03)00130-0","article-title":"Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiologic sample","volume":"66","author":"Kavanagh","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.06.039_bb0220","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.08.026","article-title":"Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: results from the national epidemiologic survey on alcohol and related conditions - III","volume":"156","author":"Kerridge","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2017.06.039_bb0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1192\/bjp.bp.106.024638","article-title":"The stigma scale: development of a standardised measure of the stigma of mental illness","volume":"190","author":"King","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0235","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/schbul\/sbp031","article-title":"Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis","volume":"36","author":"Koskinen","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0240","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/schbul\/23.2.195","article-title":"Substance use disorder and the early course of illness in schizophrenia and affective psychosis","volume":"23","author":"Kovasznay","year":"1997","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0447.2005.00554.x","article-title":"The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis","volume":"112","author":"Lambert","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2006.07.018","article-title":"Substance abuse in first-episode non-affective psychosis","volume":"88","author":"Larsen","year":"2006","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.schres.2017.06.039_bb0255","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1176\/appi.ps.201300291","article-title":"The role of experienced and anticipated discrimination in the lives of people with first-episode psychosis","volume":"65","author":"Lasalvia","year":"2014","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0260","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/schbul\/sbq153","article-title":"The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia","volume":"38","author":"Leeson","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.06.039_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0149-7189(88)90033-X","article-title":"A quality of life interview for the chronically mentally ill","volume":"11","author":"Lehman","year":"1988","journal-title":"Eval. Prog. Plan."},{"issue":"8","key":"10.1016\/j.schres.2017.06.039_bb0270","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.socscimed.2009.12.026","article-title":"Understanding factors influencing substance use in people with recent onset psychosis: a qualitative study","volume":"70","author":"Lobbana","year":"2010","journal-title":"Soc. Sci. Med."},{"key":"10.1016\/j.schres.2017.06.039_bb0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1745-0179-2-4","article-title":"Substance abuse in first-episode schizophrenic patients: a retrospective study","volume":"2","author":"Mauri","year":"2006","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2006.06.040","article-title":"Substance misuse and cognitive functioning in early psychosis: a 2year follow-up","volume":"88","author":"McCleery","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.socscimed.2014.12.010","article-title":"Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination","volume":"126","author":"McGinty","year":"2015","journal-title":"Soc. Sci. Med."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abus. Treat."},{"issue":"9","key":"10.1016\/j.schres.2017.06.039_bb0295","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"van der Meer","year":"2015","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0300","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.schbul.a007132","article-title":"The correlates of comorbid antisocial personality disorder in schizophrenia","volume":"30","author":"Moran","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/schbul\/21.3.367","article-title":"Expectations and motives for substance use in schizophrenia","volume":"21","author":"Mueser","year":"1995","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2017.06.039_bb0310","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1037\/0021-843X.106.3.473","article-title":"Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia","volume":"106","author":"Mueser","year":"1997","journal-title":"J. Abnorm. Psychol."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0315","doi-asserted-by":"crossref","first-page":"278","DOI":"10.15288\/jsa.1999.60.278","article-title":"Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders","volume":"60","author":"Mueser","year":"1999","journal-title":"J. Stud. Alcohol"},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0320","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/schbul\/sbj068","article-title":"Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders","volume":"32","author":"Mueser","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0325","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/0004867415599846","article-title":"Cannabis use in first episode psychosis: meta-analysis of prevalence, and the time course of initiation and continued use","volume":"50","author":"Myles","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0330","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009888","article-title":"Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study","volume":"6","author":"Patel","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.schres.2017.06.039_bb0335","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0004867412461957","article-title":"Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia?","volume":"47","author":"Power","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0340","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S0033291798007399","article-title":"Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients","volume":"28","author":"Rabinowitz","year":"1998","journal-title":"Psychol. Med."},{"issue":"19","key":"10.1016\/j.schres.2017.06.039_bb0345","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0350","first-page":"567","article-title":"Emotional disturbance and mental retardation: diagnostic overshadowing","volume":"86","author":"Reiss","year":"1982","journal-title":"Am. J. Ment. Defic."},{"key":"10.1016\/j.schres.2017.06.039_bb0355","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/archpsyc.60.9.940","article-title":"Cost-effectiveness of supported housing for homeless persons with mental illness","volume":"60","author":"Rosenheck","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2017.06.039_bb0360","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","article-title":"Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia","volume":"163","author":"Rosenheck","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2017.06.039_bb0365","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1037\/0022-3514.57.6.1069","article-title":"Happiness is everything, or is it? Explorations on the meaning of psychological well-being","volume":"57","author":"Ryff","year":"1989","journal-title":"J. Pers. Soc. Psychol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.06.039_bb0370","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2013.04.017","article-title":"Differences in associations between cannabis and stimulant disorders in first admission psychosis","volume":"147","author":"Sara","year":"2013","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2017.06.039_bb0375","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1177\/0004867414533838","article-title":"Stimulant and other substance use disorders in schizophrenia: prevalence, correlates and impacts in a population sample","volume":"48","author":"Sara","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugpo.2014.07.011","article-title":"Probability and predictors of the cannabis gateway effect: a national study","volume":"26","author":"Secades-Villa","year":"2015","journal-title":"Int. J. Drug Policy"},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0385","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK national EDEN study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/NMD.0b013e3181cc0d41","article-title":"Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers","volume":"198","author":"de la Serna","year":"2010","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.schres.2017.06.039_bb0395","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1034\/j.1600-0447.2001.00452.x","article-title":"Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder","volume":"104","author":"Sevy","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2010.03.037","article-title":"Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia","volume":"120","author":"Sevy","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2017.06.039_bb0405","first-page":"134","article-title":"The relationship between cannabidiol and psychosis: a review","volume":"27","author":"Silva","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0410","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0924-9338(03)00027-0","article-title":"Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects","volume":"18","author":"Sorbara","year":"2003","journal-title":"Eur. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2017.06.039_bb0415","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.schres.2014.04.003","article-title":"The effect of drug use on the age at onset of psychotic disorders in an Australian cohort","volume":"156","author":"Stefanis","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2017.06.039_bb0420","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2004.10.006","article-title":"Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up","volume":"75","author":"Stirling","year":"2005","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2017.06.039_bb0425","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.psychres.2015.07.025","article-title":"Clinical variables associated with suicide attempts in schizophrenia before and after the first episode","volume":"229","author":"Togay","year":"2015","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0430","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpsychires.2012.11.009","article-title":"The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS)","volume":"47","author":"Tosato","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0435","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1192\/bjp.bp.108.057471","article-title":"Impact of persistent substance misuse on 1-year outcome in first-episode psychosis","volume":"195","author":"Turkington","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0440","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00127-004-0713-0","article-title":"Substance misuse at presentation to an early psychosis program","volume":"39","author":"Van Mastrigt","year":"2004","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"5","key":"10.1016\/j.schres.2017.06.039_bb0445","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0447.1999.tb10883.x","article-title":"Suicidality and substance misuse in first-admitted subjects with psychotic disorder","volume":"100","author":"Verdoux","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.schres.2017.06.039_bb0450","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1034\/j.1600-0447.2001.00202.x","article-title":"Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects","volume":"103","author":"Verdoux","year":"2001","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2017.06.039_bb0455","first-page":"892","article-title":"Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis","volume":"39","author":"Wade","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2017.06.039_bb0460","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.105.017236","article-title":"Substance misuse in first-episode psychosis: 15-month prospective follow-up study","volume":"189","author":"Wade","year":"2006","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2017.06.039_bb0465","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4088\/JCP.v68n0517","article-title":"Impact of severity of substance use disorder on symptomatic and functional outcome in young individuals with first-episode psychosis","volume":"68","author":"Wade","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2017.06.039_bb0470","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0893-133X(01)00367-0","article-title":"From first drug use to drug dependence: developmental periods of risk for dependence upon marijuana, cocaine, and alcohol","volume":"26","author":"Wagner","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.schres.2017.06.039_bb0475","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2017.06.039_bb0480","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1037\/0278-6133.17.3.269","article-title":"Autonomous regulation and long-term medication adherence in adult outpatients","volume":"17","author":"Williams","year":"1998","journal-title":"Health Psychol."},{"issue":"9","key":"10.1016\/j.schres.2017.06.039_bb0485","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1176\/ps.62.9.pss6209_1007","article-title":"Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment","volume":"62","author":"Wisdom","year":"2011","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2017.06.039_bb0490","series-title":"The Mental Health Recovery Measure","author":"Young","year":"2003"},{"issue":"1","key":"10.1016\/j.schres.2017.06.039_bb0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.v58n0104","article-title":"Applicability of telemedicine for assessing patients with schizophrenia: acceptance and reliability","volume":"58","author":"Zarate","year":"1997","journal-title":"J. Clin. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641730378X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641730378X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T00:52:55Z","timestamp":1569718375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641730378X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":99,"alternative-id":["S092099641730378X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2017.06.039","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demographic and clinical correlates of substance use disorders in first episode psychosis","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2017.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}